Milpitas, CA, United States of America

Anindya Sarkar

This inventor holds 41 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 18 EPO patents, primarily in Image Analysis Technologies. Top assignees: Ventana Medical Systems, Inc., The Cleveland Clinic Foundation, The University of Melbourne. Active years: 2017-2025.

USPTO Granted Patents = 41 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (2017 - 2019)
  • Milpitas, CA (US) (2017 - 2024)
  • Tucson, AZ (US) (2021 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Multi-Spectral Imaging
Automated Hybridization
Tissue Scoring
Image Registration
Foreground Segmentation
Deep Learning
Pathology Analysis
Gene Expression Detection
Histopathology Unmixing
Quantitative Scoring
Digital Imaging
Tumor Heterogeneity
41 patents (USPTO):Explore Patents

Title: Anindya Sarkar - Innovator from Milpitas, CA

Introduction: Anindya Sarkar is a renowned inventor based in Milpitas, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Anindya Sarkar holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Anindya Sarkar has worked with leading tech companies, research institutions, and universities, playing a pivotal role in developing innovative solutions for complex challenges.

Collaborations: Anindya Sarkar has collaborated with top engineers, scientists, and researchers worldwide, fostering a culture of innovation and knowledge sharing in the tech community.

Conclusion: Anindya Sarkar's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…